No Prescription |
 |
 | ||
|
Dilantin Generic Phenytoin |
|
| ||
No Prescription » Prescription Drugs 6 » Dilantin Generic Phenytoin Phenytoin is used to treat various types of convulsions and seizures. Phenytoin acts on the brain and nervous system in the treatment of epilepsy.Phenytoin comes as a capsule extended-release (long-acting) capsule chewable tablet and liquid to take by mouth. It usually is taken two or three times a day. However the extended-release capsules may be taken only once a day usually at bedtime. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take phenytoin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Shake the liquid well before each use.Do not open crush or chew the extended-release capsules; swallow them whole.Continue to take phenytoin even if you feel well. Do not stop taking phenytoin without talking to your doctor especially if you have taken large doses for a long time. Abruptly stopping the drug can cause seizures. Your doctor probably will decrease your dose gradually. Buy Dilantin Generic Phenytoin and other Prescription Drugs 6 products online at Medstore. Buy Online at Medstore - Click Here!
About Dilantin Generic Phenytoin: Product Type: Prescription Drugs 6 Dilantin ( Generic Phenytoin ) Dilantin (Generic Phenytoin) Generic Phenytoin 100mg 200 caps 30mg Generic Phenytoin Dilantin
View more Prescription Drugs 6 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
